Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, May 5, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the first quarter of 2021.

Conference Call & Webcast Details
Date:	Wednesday, May 5, 2021
Time:	8:00 am Eastern Time
Toll Free:	[phone]
International:	[phone]
Conference ID:	7587147
Webcast:	https://edge.media-server.com/mmc/p/vfqo9b5q

The live webcast of the conference call can also be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
[phone]
[e-mail]

Investors
Ron Moldaver
[phone]
[e-mail]